Sirion’s Post-operative Eye Drug Durezol Gets May 29 FDA Panel Review
This article was originally published in The Pink Sheet Daily
Executive Summary
Dermatologic and Ophthalmic Drugs Advisory Committee evaluates the topical ophthalmic steroid’s NDA.